Ligand profile
ZINC100545802
Virtual-screening candidate from ZINC.
Bound to: VK055_0054 — trehalose-phosphatase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100545802- UniProt (similar protein)
E1WGG9- Tanimoto
- 0.556
- Target protein
- VK055_0054
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 200.5
- −1 ≤ LogP ≤ 5 -6.01
- MW ≤ 500 Da 342.3
- LogP ≤ 5 -6.01
- H-bond donors ≤ 5 9
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 200.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1OOC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O
InChI=1S/C12H22O11/c13-1-2-3(14)4(15)10(21)12(22-2)23-11-8(19)6(17)5(16)7(18)9(11)20/h2-21H,1H2/t2-,3+,4+,5-,6-,7+,8-,9-,10-,11-,12-/m1/s1InChI=1S/C12H22O11/c13-1-2-3(14)4(15)10(21)12(22-2)23-11-8(19)6(17)5(16)7(18)9(11)20/h2-21H,1H2/t2-,3+,4+,5-,6-,7+,8-,9-,10-,11-,12-/m1/s1
VCWMRQDBPZKXKG-BJBMSVMHSA-NVCWMRQDBPZKXKG-BJBMSVMHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- T6S
- Homolog
- E1WGG9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100545802 →
- ZINC ZINC20 ZINC100545802 →
- UniProt UniProt E1WGG9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100545802”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0054.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).